Guaifenesin; Pseudoephedrine Hydrochloride Patent Expiration
Guaifenesin; Pseudoephedrine Hydrochloride is Used for treating symptoms of respiratory congestion and congestion in the nasal passages. It was first introduced by Rb Health Us Llc
Guaifenesin; Pseudoephedrine Hydrochloride Patents
Given below is the list of patents protecting Guaifenesin; Pseudoephedrine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mucinex D | US6372252 | Guaifenesin sustained release formulation and tablets |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex D | US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex D | US7838032 | Sustained release of guaifenesin |
Apr 28, 2020
(Expired) | Rb Hlth |
Guaifenesin; Pseudoephedrine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Guaifenesin; Pseudoephedrine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Guaifenesin; Pseudoephedrine Hydrochloride. The first generic version for Guaifenesin; Pseudoephedrine Hydrochloride was by Actavis Laboratories Fl Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc and was approved on May 27, 2015. And the latest generic version is by Granules India Ltd and was approved on Aug 22, 2022.
Given below is the list of companies who have filed for Guaifenesin; Pseudoephedrine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS FL
Actavis Laboratories Fl Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Guaifenesin; Pseudoephedrine Hydrochloride. All of these versions come by the name GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG; 60MG | tablet, extended release | Over the counter | ORAL | N/A | May 27, 2015 |
| 1.2GM; 120MG | tablet, extended release | Over the counter | ORAL | N/A | May 27, 2015 |
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Guaifenesin; Pseudoephedrine Hydrochloride. All of these versions come by the name GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG; 60MG | tablet, extended release | Over the counter | ORAL | N/A | Mar 25, 2020 |
| 1.2GM; 120MG | tablet, extended release | Over the counter | ORAL | N/A | Mar 25, 2020 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Guaifenesin; Pseudoephedrine Hydrochloride. All of these versions come by the name GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG; 60MG | tablet, extended release | Over the counter | ORAL | N/A | Dec 29, 2017 |
| 1.2GM; 120MG | tablet, extended release | Over the counter | ORAL | N/A | Dec 29, 2017 |
4. GRANULES
Granules India Ltd has filed for 2 different strengths of generic version for Guaifenesin; Pseudoephedrine Hydrochloride. All of these versions come by the name GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG; 60MG | tablet, extended release | Discontinued | ORAL | N/A | Aug 22, 2022 |
| 1.2GM; 120MG | tablet, extended release | Discontinued | ORAL | N/A | Aug 22, 2022 |
Manufacturing Plant Locations New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
| India |
| |||||||||||
5. L PERRIGO CO
L Perrigo Co has filed for 2 different strengths of generic version for Guaifenesin; Pseudoephedrine Hydrochloride. All of these versions come by the name GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by L Perrigo Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 600MG; 60MG | tablet, extended release | Over the counter | ORAL | N/A | Feb 1, 2022 |
| 1.2GM; 120MG | tablet, extended release | Over the counter | ORAL | N/A | Feb 1, 2022 |
6. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Guaifenesin; Pseudoephedrine Hydrochloride. All of these versions come by the name GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.2GM; 120MG | tablet, extended release | Over the counter | ORAL | N/A | Apr 28, 2020 |
| 600MG; 60MG | tablet, extended release | Over the counter | ORAL | N/A | Apr 28, 2020 |